Patent ID: 6165998
Filing Date: 2000-12-26
Classification: A61K,C07C

Abstract:
A pharmaceutical composition comprising a compound selected from the group consisting of4-[2-[3-(trifluoromethyl)phenyl]diazenyl]-phenol;3-[2-(6-bromo-2,4-dinitrophenyl)diazenyl]-(2-methyl-4-(N-n-butyl, N-2-hydroxyethyl)-aniline;4-[2-[3-(trifluoromethyl)phenyl]diazenyl]-anisole;4-[2-[3-(trifluoromethyl)phenyl]diazenyl]-2-hydroxy-phenol;4-[2-[3-(methyl)phenyl]diazenyl]-phenol;(4-[2-[2-nitro-4-(trifluoromethyl)phenyl]diazenyl]-phenol;4-[2-[3-(trifluoromethyl)phenyl]diazenyl]-2-nitrophenol;5-[2-[3-(trifluoromethyl)phenyl]diazenyl]-2-hydroxy-benzoic acid;5-[2-[3-(trifluoromethyl)phenyl]diazenyl]-2-hydroxy-benzaldehyde4-[2-[3-(chloro)phenyl]diazenyl]phenol;4-[2-[2-fluoro-3-(trifluoromethyl)phenyl]diazenyl]phenol;4-[2-[4-fluoro-3-(trifluoromethyl-phenyl]diazenyl]phenol;4-[2-[6-fluoro-3-(trifluoromethyl)phenyl]diazenyl]phenol;4-[2-[3,5-(di-trifluoromethyl)phenyl]diazenyl]phenol;4-[2-[3-(trifluoromethyl)-5-(methoxy)phenyl]diazenyl]phenol;4-[2-[3-(trifluoromethyl)phenyl]diazenyl]-2-cyano-phenol;4-[2-[3-(trifluoromethyl)phenyl]diazenyl]-2-(hydroxymethyl)-phenol;4-[2-[3-(trifluoromethyl)phenyl]diazenyl]-3-cyano-phenol;4-[2-[3-(trifluoromethyl)phenyl]diazenyl]-3-(hydroxymethyl)-phenol;4-[2-[3-(trifluoromethyl)phenyl]diazenyl]-3-methyl-phenol;4-[2-[3-(trifluoromethyl]phenyl)diazenyl]-3-nitro-phenol;4-benzoxy-N-[3-(trifluoromethyl)phenyl]benzamide; and4-hydroxy-N-[3-(trifluoromethyl)phenyl]benzamide;or a pharmaceutically acceptable salt thereof;and a pharmaceutically acceptable carrier.